Additional studies showed that hnRNPA2/B1 enhanced the stability of interleukin-binding factor 3 (ILF3) in an m6A-dependent manner to promote proliferation in multiple myeloma cells [108]. This evidence concerns the gene HNRNPA2B1 and plasma cell myeloma.